Burkholderia cenocepacia Lipopolysaccharide, Lipid A, and Proinflammatory Activity
- 1 July 2004
- journal article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 170 (1) , 70-77
- https://doi.org/10.1164/rccm.200304-592oc
Abstract
Organisms from the Burkholderia cepacia complex are important pathogens in cystic fibrosis and are associated with increased rates of sepsis and death. These organisms comprise nine closely related species known as genomovars. B. cenocepacia (genomovar III) is the most prevalent and appears the most virulent. We investigated the biological activity of a reference panel of strains using whole-cell lysates to induce septic-shock related cytokines from differentiated human monocytic cells. We found varying biological activity within and between genomovars, with B. cenocepacia strains possessing the greatest cytokine induction activity. This activity was CD-14 dependent, suggesting that LPS was responsible for the cytokine induction. Cytokine induction was not simply related to the expression of rough or smooth LPS. We purified LPS from two strains, B. cenocepacia LMG 12614 and B. multivorans LMG 14273, each possessing rough LPS. Divergence in biological activity of the two genomovars was preserved when human monocytic cells were stimulated with purified LPS. Lipid A purified from LMG 14273 and LMG 12614 were analyzed by matrix-assisted laser desorption ionization/time of flight mass spectrometry. Lipid A from the less effective cytokine inducer LMG 14273 was found to be missing a beta-hydroxymyristate (3-OH C14:0) relative to the lipid A of B. cenocepacia LMG 12614.Keywords
This publication has 51 references indexed in Scilit:
- Long term results of lung transplantation for cystic fibrosisEuropean Journal of Cardio-Thoracic Surgery, 2002
- Burkholderia cepacia complex infection in patients with cystic fibrosisJournal of Medical Microbiology, 2002
- Burkholderia anthinasp. nov. andBurkholderia pyrrocinia, two additionalBurkholderia cepaciacomplex bacteria, may confound results of new molecular diagnostic toolsFEMS Immunology & Medical Microbiology, 2002
- Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients.International Journal of Systematic and Evolutionary Microbiology, 2001
- Burkholderia cepacia in Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 1999
- BURKHOLDERIA CEPACIAClinics in Chest Medicine, 1998
- Occurrence of Multiple Genomovars of Burkholderia cepacia in Cystic Fibrosis Patients and Proposal of Burkholderia multivorans sp. nov.International Journal of Systematic and Evolutionary Microbiology, 1997
- Burkholderia cepacia: medical, taxonomic and ecological issuesJournal of Medical Microbiology, 1996
- Outcome for patients colonised with Burkholderia cepacia in a Birmingham adult cystic fibrosis clinic and the end of an epidemic.Thorax, 1996
- Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosisThe Lancet, 1993